Trial Profile
Clinical Trials Insight: 700053144
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2010
Price :
$35
*
At a glance
- Drugs Angiotensin inhibitor vaccine (Primary) ; CoVaccineHT
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors BTG
- 03 Feb 2010 New trial record.
- 21 Jan 2010 The trial is anticipated to start in the second half of 2010, according to a BTG media release.